26 May 2013
Keywords: varied, potential, chiron, corp, some, analysts, lowered
Article | 09 December 1996
While some analysts lowered their ratings on the US biotechnology firm
Chiron Corporation after clinical trials of a new vaccine ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 December 1996
24 May 2013
© 2013 thepharmaletter.com